Interventional Radiology

Committed to Interventional Oncology
Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide.

TheraSphere receives FDA Approval!
After 20 years as a humanitarian exemption device (HDE), the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 therapy indicated for HCC. This means institutional review board (IRB) approval of TheraSphere is no longer required by the FDA.

Eluvia™ Drug-Eluting Stent and Ranger™ Drug-Coated Balloon
Boston Scientific is committed to advancing science in the fight against PAD. Our proven results are backed by Level-1 Randomized Controlled Trials.
Reimbursement
Resources for patients and healthcare professionals.
Product Catalogs
View and download the coronary and peripheral vascular product catalogs.

Talk to a representative
Want to learn more about products and services? One of our sales representatives will be happy to contact you.

TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd., a wholly owned subsidiary of Boston Scientific Corporation.